{
  "ticker": "NVO",
  "name": "Novo Nordisk A/S",
  "price": 50.88,
  "market_cap": 226084241408,
  "revenue_ttm": 49550423670.93556,
  "net_income_ttm": 16292608484.722883,
  "ocf_ttm": 19434383208.280933,
  "capex_ttm": 9865087850.684452,
  "sbc_ttm": 0.0,
  "buyback_ttm": 1394024175.2272217,
  "total_debt": 15890839381.85021,
  "cash_and_equivalents": 5115608706.096246,
  "book_value_ttm": 26674077179.232353,
  "shares_outstanding": 3368607341,
  "beta": 1.2,
  "roe": 71.47,
  "analyst_growth_estimate": 5.1,
  "forward_eps": 3.4471674,
  "dividend_yield": 339.0,
  "sector_type": "BioTech",
  "currency_code": "USD",
  "last_updated": "2026-01-02T12:40:54Z"
}